These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25750336)

  • 1. Prognostic factor of severe complications in patients with hypopharyngeal cancer with primary concurrent chemoradiotherapy.
    Chen LY; Huang CC; Tsou YA; Bau DT; Tsai MH
    Anticancer Res; 2015 Mar; 35(3):1735-41. PubMed ID: 25750336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
    Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
    Chen SW; Yang SN; Liang JA; Lin FJ; Tsai MH
    Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancer.
    Tennant PA; Cash E; Bumpous JM; Potts KL
    Head Neck; 2014 Nov; 36(11):1628-33. PubMed ID: 24115178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Tanaka N; Tanaka T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Sep; 34(9):5205-10. PubMed ID: 25202116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
    Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
    Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the results of chemoradiotherapy and surgical treatment for hypopharyngeal cancer.
    Demirci U; Özmen ÖA; Demiröz C; Kasapoğlu F; Coşkun HH; Özkan L; Onart S
    Kulak Burun Bogaz Ihtis Derg; 2013; 23(5):275-81. PubMed ID: 24010801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with advanced hypopharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Krstevska V; Stojkovski I; Zafirova-Ivanovska B; Crvenkova S
    J BUON; 2012; 17(2):327-36. PubMed ID: 22740214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-surgical multimodality treatment for locally advanced (T3-4) hypopharyngeal cancer: the impact of pre-treatment hemoglobin level.
    Suzuki G; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Yamazaki H; Nakamura S; Yoshida K
    Anticancer Res; 2013 Dec; 33(12):5561-5. PubMed ID: 24324098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitive radiotherapy for T1-2 hypopharyngeal cancer: a single-institution experience.
    Nakajima A; Nishiyama K; Morimoto M; Nakamura S; Suzuki O; Kawaguchi Y; Miyagi K; Fujii T; Yoshino K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e129-35. PubMed ID: 21640496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.
    Huh G; Ahn SH; Suk JG; Lee MH; Kim WS; Kwon SK; Ock CY; Keam B; Heo DS; Kim JH; Wu HG
    Jpn J Clin Oncol; 2020 Feb; 50(2):185-192. PubMed ID: 31711185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laryngeal preservation for hypopharyngeal cancer by radiotherapy with S-1 and vitamin A(TAR therapy)].
    Nakashima T; Toh S; Shiratsuchi H; Yasumatsu R; Fukushima J; Nakamura K; Shioyama Y; Komune S
    Gan To Kagaku Ryoho; 2012 May; 39(5):759-63. PubMed ID: 22584327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
    Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified TALK Score for Japanese Patients with Laryngeal and Hypopharyngeal Cancers to Predict the Possibility of Laryngeal Preservation by Concurrent Chemoradiotherapy.
    Otsuki N; Matsui M; Takahashi M; Sasaki R; Kiyota N; Usami M; Nibu KI
    Kobe J Med Sci; 2018 Apr; 63(4):E113-E122. PubMed ID: 29955023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional outcomes of chemoradiation in patients with head and neck cancer.
    Tulunay-Ugur OE; McClinton C; Young Z; Penagaricano JA; Maddox AM; Vural E
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):64-8. PubMed ID: 22951428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in patients treated for advanced hypopharyngeal or laryngeal cancer.
    Guibert M; Lepage B; Woisard V; Rives M; Serrano E; Vergez S
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):218-23. PubMed ID: 21613002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological and prognostic analysis of 178 patients with hypopharyngeal cancer].
    Hua YH; Hu QY; Fu ZF; Tang Q; Wang WD
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jul; 47(7):540-4. PubMed ID: 22932236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of prognostic factors of chemoradiation therapy for advanced hypopharyngeal cancer--does tumor volume correlate with central necrosis and tumor pathology?
    Tsou YA; Hua JH; Lin MH; Tsai MH
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(4):206-12. PubMed ID: 16508339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity, quality of life, and functional outcomes of 176 hypopharyngeal cancer patients treated by (chemo)radiation: the impact of treatment modality and radiation technique.
    Al-Mamgani A; Mehilal R; van Rooij PH; Tans L; Sewnaik A; Levendag PC
    Laryngoscope; 2012 Aug; 122(8):1789-95. PubMed ID: 22833307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.